Longtime Crusader Against OxyContin Begins To See The Fruits Of Her Struggle
Barbara Van Rooyan lost her son to the drug 15 years ago and has fought ceaselessly since then to hold Purdue Pharma accountable for its role in the opioid crisis.
The independent source for health policy research, polling, and news.
521 - 540 of 985 Results
Barbara Van Rooyan lost her son to the drug 15 years ago and has fought ceaselessly since then to hold Purdue Pharma accountable for its role in the opioid crisis.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
Nearly 2 million more Americans were uninsured in 2018 than in the previous year, according to the Census Bureaus annual report. Plus, the Trump administration announced plans to ban flavored vape liquids, and Congress is back and working to address high prescription drug prices and surprise medical bills. This week, Joanne Kenen of Politico, Tami Luhby of CNN and Rebecca Adams of CQ Roll Call join KHNs Julie Rovner to discuss these issues and more.
In the first six months of this year, pharmaceutical firms and their trade groups donated almost $4 million to the campaigns of a variety of senators and House members.
Almost 80% of Americans support efforts in Congress to protect patients from bills that come from doctors or hospitals that were outside their insurance network.
So far this year, 33 states have enacted more than 50 measures to address drug prices, affordability and access. Congress is eyeing the efforts to see what works.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
One out of every 13 seniors in America struggles to get enough food to eat while the federal program intended to help hasnt kept pace with the graying population. KHN Midwest editor/correspondent Laura Ungar explains what you need to know about this largely hidden problem.
In the background, advisers weigh the risks of rolling out a comprehensive health care proposal. Peering into the crystal ball, heres a glimpse of what could be included in the GOP plan.
One out of every 13 older Americans struggles to find enough food to eat while the federal program intended to help hasnt kept pace with the graying population.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
Congress has a variety of reforms in mind that could roil the drugmaking business and potentially slash prices.
Before Medicare for All, there was just Medicare, the federal program that provides insurance to 60 million Americans. This week, KHNs Julie Rovner talks to Tricia Neuman of the Kaiser Family Foundation about how Medicare works and whom it serves. Then, Joanne Kenen of Politico, Paige Winfield Cunningham of The Washington Post and Kimberly Leonard of the Washington Examiner join Rovner to talk about some current Medicare issues being debated in Washington, D.C.
The tax on generous health plans originally envisioned as a way to help pay for the ACA and change consumers behavior has never been implemented, and Congress is considering repeal.
You asked about drug prices, the Cadillac tax on generous insurance plans and why Americans dont know that most other countries also have combination public-private insurance systems. This week, Anna Edney of Bloomberg News, Alice Miranda Ollstein of Politico and Caitlin Owens of Axios join KHNs Julie Rovner to answer those questions.
The recent tragic mass shootings have refocused efforts to treat gun violence as a public health issue rather than strictly a law enforcement problem. Margot Sanger-Katz of The New York Times, Alice Miranda Ollstein of Politico and Mary Agnes Carey of Kaiser Health News join KHNs Julie Rovner to discuss this, plus the health implications of the budget deal passed by Congress and signed by President Donald Trump, as well as reaction from Canada to a proposal to allow broader imports of its prescription drugs. Plus, for extra credit, the panelists recommend their favorite health stories of the week.
A case of questionable logic.
Known as authorized generics, in-house spinoffs of brand-name drugs quietly undermine the competition.
Health care was a major topic at the Democratic presidential candidate debates in Detroit on Tuesday and Wednesday, but the focus on plan minutiae may have left viewers more confused than edified. Alice Ollstein of Politico, Kimberly Leonard of the Washington Examiner and Caitlin Owens of Axios join KHNs Julie Rovner to discuss the points made by the candidates plus a series of Trump administration health initiatives on drug prices and hospital shopping.
The proposed rules would require hospitals to provide far more detail about the actual prices they charge insurers for patients care.
穢 2026 KFF